Medical Excellence Capital Closes Maiden Fund, at $145M

Medical Excellence Capital, a Nissequogue, NY-based early-stage life science enterprise agency fashioned to take a position in disruptive applied sciences in precision well being, held a $145m closing shut of Medical Excellence Capital Companions, LP.

MEC was fashioned to leverage the mixture of a confirmed funding crew and a singular community of physician-scientists to concentrate on firm creation and enterprise investing. Goal funding areas embrace cell remedy, gene remedy, AI/ML utilized to drug discovery, artificial biology, and regenerative medication.

Based by John Prufeta, founder and basic associate, Medical Excellence Capital supplies firm creation, seed, and early-stage capital to innovators within the areas of cell remedy, gene remedy, AI/ML utilized to drug discovery, immunology/drug resistance, and regenerative medication. MEC invests solely in excessive potential corporations the place its experience, insights, and international community can promote acceleration and maximized worth creation. It’s intently aligned and networked with Medical Excellence Group (MedEx), an intensive international, personal well being advisory medical community and household workplace well being care platform, constructed and refined during the last 15 years by Mr. Prufeta. This platform features a community of greater than 1,200 prime doctor and scientist leaders throughout 33 main educational medical facilities and analysis establishments within the US. The Medical Excellence Capital crew operates out of the numerous well being care innovation markets New York, California, and Pennsylvania.

The crew consists of Brian Halak, Ph.D., Eric Heil, MBA, and Kim Kamdar, Ph.D., whereas the MEC Scientific Advisory Board is comprised of:

  • Euan Ashley, M.D., Ph.D., Stanford Medical Faculty – Affiliate Dean and Professor of Genetics and Precision Well being Cardiovascular, and Knowledge Science
  • Gregg Semenza, M.D., Ph.D., Johns Hopkins Medication – 2019 Nobel Prize Laureate in Medication; Professor of Genetic Medication
  • Steven Tsang, M.D., Ph.D., Columbia Medication – Professor of Ophthalmology, and Pathology and Cell Biology; Director of the Columbia Stem Cell Institute
  • Douglas Wallace, Ph.D., Kids’s Hospital of Philadelphia (CHOP) & College of Pennsylvania – Director of the Middle for Mitochondrial and Epigenomic Medication

Medical Excellence Capital Closes Maiden Fund, at $145M. Congratulations to the entire team. I wish you great success in this endeavour.

Shishir Gupta, Founder and CEO, StartupLanes

Don’t keep wondering about funding, you can also raise funds. Learn how to raise funds here: Yes I want to raise funds.

If you are an emerging startup and are looking for investors to raise funds, StartupLanes has its own angel network and investment banking services and is connected to angel investors and VCs in 15 countries that ensure that our member startups have easy access to external funds to scale up constantly.

You can subscribe to our news posts by entering your email in the box on the right side of this page.

Check out our YouTube channel for insightful content from the Indian startup ecosystem.

Or join our Whatsapp group to interact with other founders: Yes, I want to join the Whatsapp group.

The right investment is key to beating inflation and growing your wealth. Do you wish to become an angel investor? Yes, I want to be an angel investor.

Are you a startup and facing challenges in your business? Do you want to grow your business? It is not as difficult as it sounds. Learn how to grow your business here- Yes, I want to grow my business. For any rectifications, reach out to ashu@startuplanes.com